Raloxifene hydrochloride

• Post Date:

  Feb 02,2016

• Expiry Date:

  Jul 31,2016

• Detailed Description:

  Cas No. :82640-04-8 Payment Method: money gram, western union, bank transfer, bit
  Alias: RALOXIFENE HCL; ly156758; KEOXIFENE;KEOXIFENE HYDROCHLORIDE;LY 139481;AKOS 92138
  
  Product Details:
  Place of Origin: China
  Certification: ISO9001
  Brand:YuanCheng
  
  Payment & Shipping Terms:
  
  Minimum Order Quantity:1kg
  Supply Ability:500kg/month
  Delivery Time:within 24 hours after payment
  
  Payment Terms:Western Union, MoneyGram, T/T
  Package:25kg/cardboad drum
  Appearance:light yellow
  
  Product Description:
  CAS: 82640-04-8
  M.F.: C28H28ClNO4S
  M.W. :510.04
  Purity:99.8%
  M.P.: 250-253°C
  M.S.:
  
  
  
  EVISTA (raloxifene hydrochloride) is an estrogen agonist/antagonist, commonly referred to as a selective estrogen receptor modulator (SERM) that belongs to the benzothiophene class of compounds
  
  The chemical designation is methanone, [6-hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl]-[4-[2-(1-piperidinyl)ethoxy]phenyl]-, hydrochloride. Raloxifene hydrochloride (HCl) has the empirical formula C28H27NO4S.HCl, which corresponds to a molecular weight of 510.05. Raloxifene HCl is an off-white to pale-yellow solid that is very slightly soluble in water.
  
  EVISTA (raloxifene) is supplied in a tablet dosage form for oral administration. Each EVISTA tablet contains 60 mg of raloxifene HCl, which is the molar equivalent of 55.71 mg of free base. Inactive ingredients include anhydrous lactose, carnauba wax, crospovidone, FD&C Blue No. 2 aluminum lake, hypromellose, lactose monohydrate, magnesium stearate, modified pharmaceutical glaze, polyethylene glycol, polysorbate 80, povidone, propylene glycol, and titanium dioxide.
  
  
  Usage:
  Reduction in the incidence of invasive breast cancer in postmenopausal women with osteoporosis.
  in 2006, the National Cancer Institute announced that raloxifene was as effective as tamoxifen in reducing the incidence of breast cancer in postmenopausal women at increased risk,
  

• CAS Registry Number:

  82640-04-8

• Synonyms:

  ;Raloxifene hydrochloride [USAN];6-Hydroxy-2-(p-hydroxyphenyl)benzo(b)thien-3-yl-p-(2-piperidinoethoxy)phenyl ketone, hydrochloride;Evista;Keoxifene hydrochloride;LY 156758;Methanone, (6-hydroxy-2-(4-hydroxyphenyl)benzo(b)thien-3-yl)(4-(2-(1-piperidinyl)ethoxy)phenyl)-, hydrochloride;Raloxifene HCl;UNII-4F86W47BR6;[6-hydroxy-2-(4-hydroxyphenyl)-1-benzothiophen-3-yl]{4-[2-(piperidin-1-yl)ethoxy]phenyl}methanone hydrochloride (1:1);[6-hydroxy-2-(4-hydroxyphenyl)-2,3-dihydro-1-benzothiophen-3-yl][4-(2-piperidin-1-ylethoxy)phenyl]methanone;

• Molecular Formula:

  C₂₈H₂₉NO₄S

• Molecular Weight:

  475.5992

• Molecular Structure:

  

• Company:

  Zhuzhou Yuancheng Hezhong Technology Development     [ China ]        

• Contact:

  kathyyan

• Tel:

  86-731-22292056

• Fax:

  86-731-22292056

• Email:

  mxy044@yccreate.com